The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Trends in the Aggressiveness of Cancer Care Near the End of Life
Abstract
Purpose: To characterize the aggressiveness of end-of-life cancer treatment for older adults on Medicare, and its relationship to the availability of healthcare resources. Patients and Methods: We analyzed Medicare claims of 28,777 patients 65 years and older who died within 1 year of a diagnosis of lung, breast, colorectal, or other gastrointestinal cancer between 1993 and 1996 while living in one of 11 US regions monitored by the Surveillance, Epidemiology, and End Results Program. Results: Rates of treatment with chemotherapy increased from 27.9% in 1993 to 29.5% in 1996 (P = .02). Among those who received chemotherapy, 15.7% were still receiving treatment within 2 weeks of death, increasing from 13.8% in 1993 to 18.5% in 1996 (P < .001). From 1993 to 1996, increasing proportions of patients had more than one emergency department visit (7.2% v 9.2%; P < .001), hospitalization (7.8% v 9.1%; P = .008), or were admitted to an intensive care unit (7.1% v 9.4%; P = .009) in the last month of life. Although fewer patients died in acute-care hospitals (32.9% v 29.5%; P < .001) and more used hospice services (28.3% v 38.8%; P < .001), an increasing proportion of patients who received hospice care initiated this service only within the last 3 days of life (14.3% v 17.0%; P = .004). Black patients were more likely than white patients to experience aggressive intervention in nonteaching hospitals but not in teaching hospitals. Greater local availability of hospices was associated with less aggressive treatment near death on multivariate analysis. Conclusion: The treatment of cancer patients near death is becoming increasingly aggressive over time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Greenlee, R. T., Murray, T., Bolden, S., & Wingo, P. A. (2000) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.1.7 · Cited by 3,850
Development of a comorbidity index using physician claims data
Klabunde, C. N., Potosky, A. L., Legler, J. M., & Warren, J. L. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00256-0 · Cited by 1,845
Krieger, N. (1992) · American Journal of Public Health · doi:10.2105/ajph.82.5.703 · Cited by 1,654
Quality End-of-Life Care: Patients' Perspectives
Singer, P. A., Martin, D. K., & Kelner, M. (1999) · JAMA · doi:10.1001/jama.281.2.163 · Cited by 1,287
Identifying Potential Indicators of the Quality of End-of-Life Cancer Care From Administrative Data
Earle, C. C., Park, E. R., Lai, B., Weeks, J. C., Ayanian, J. Z., & Block, S. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.059 · Cited by 894
Self-citationPOTOSKY, A. L., RILEY, G. F., LUBITZ, J. D., MENTNECH, R. M., & KESSLER, L. G. (1993) · Medical Care · doi:10.1097/00005650-199308000-00006 · Cited by 694
Emanuel, E. J., & Emanuel, L. L. (1998) · The Lancet · doi:10.1016/s0140-6736(98)90329-4 · Cited by 613
Hoyert, D. L., Kochanek, K. D., & Murphy, S. L. (1999) · PubMed · Cited by 357
Research works printed but not linked: 13
- 10.1093/oxfordjournals.annonc.a058808 · doi:10.1093/oxfordjournals.annonc.a058808
- Comis RL, Friedland DM: New chemotherapy agents in the treatment of advanced non-small cell lung cancer: An update including data from the Seventh World conference on Lung Cancer. Lung Cancer 12: S63,1995-S99, (suppl 2) · doi:10.1016/s0169-5002(10)80007-8
- 10.1093/oxfordjournals.annonc.a059040 · doi:10.1093/oxfordjournals.annonc.a059040
- 10.1002/(SICI)1097-0142(19980815)83:4<679::AID-CNCR8>3.0.CO;2-F · doi:10.1002/(sici)1097-0142(19980815)83:4<679::aid-cncr8>3.0.co;2-f
- 10.1097/00001813-199801000-00002 · doi:10.1097/00001813-199801000-00002
- Institute of Medicine: Improving Palliative Care for Cancer . Washington, DC, National Academy Press, p,2001 1
- Kurowski B: Cancer carve outs, specialty networks, and disease management: A review of their evolution, effectiveness, and prognosis. Am J Manag Care 4: SP71,1998-SP89,
- 10.1002/(SICI)1097-0142(19980515)82:10+<2061::AID-CNCR15>3.0.CO;2-9 · doi:10.1002/(sici)1097-0142(19980515)82:10+<2061::aid-cncr15>3.0.co;2-9
- 10.1002/1097-0142(19951201)76:11<2343::AID-CNCR2820761124>3.0.CO;2-# · doi:10.1002/1097-0142(19951201)76:11<2343::aid-cncr2820761124>3.0.co;2-#
- Ries LAG, Kosary CL, Hankey BF, et al: SEER Cancer Statistics Review, 1973-1994 . Bethesda, MD, National Cancer Institute, NIH publication 97-2789, 1997
- Institute of Medicine: Approaching Death . Washington, DC, National Academy Press, 1997
- 10.1111/j.1532-5415.1997.tb05185.x · doi:10.1111/j.1532-5415.1997.tb05185.x
- 10.1016/S0885-3924(98)00132-8 · doi:10.1016/s0885-3924(98)00132-8
Cited by
Wright, A. A. (2008) · JAMA · doi:10.1001/jama.300.14.1665 · Cited by 2,788
“This included specific services that have been defined in the literature as indicators of aggressive medical care, including admission to an intensive care unit, ventilation, resuscitation, chemotherapy, or use of a feeding tube near death.(35)”
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Edwards, B. K., Brown, M. L., Wingo, P. A., Howe, H. L., Ward, E., Ries, L. A. G., Schrag, D., Jamison, P. M., Jemal, A., Wu, X. C., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji289 · Cited by 952
Louvet, C., Labianca, R., Hammel, P., Lledo, G., Zampino, M. G., André, T., Zaniboni, A., Ducreux, M., Aitini, E., Taïeb, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.023 · Cited by 950
Aggressiveness of Cancer Care Near the End of Life: Is It a Quality-of-Care Issue?
Earle, C. C., Landrum, M. B., Souza, J. M., Neville, B. A., Weeks, J. C., & Ayanian, J. Z. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8253 · Cited by 949
Self-citationHealth Care Costs in the Last Week of Life: Associations With End-of-Life Conversations
Zhang, B., Wright, A. A., Huskamp, H. A., Nilsson, M. E., Maciejewski, M. L., Earle, C. C., Block, S. D., Maciejewski, P. K., & Prigerson, H. G. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.587 · Cited by 898
Self-citationHalpern, N. A., & Pastores, S. M. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b090d0 · Cited by 817
Wright, A. A., Keating, N. L., Balboni, T. A., Matulonis, U. A., Block, S. D., & Prigerson, H. G. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3863 · Cited by 797
Self-citationMaltoni, M., Caraceni, A., Brunelli, C., Broeckaert, B., Christakis, N., Eychmueller, S., Glare, P., Nabal, M., Viganò, A., Larkin, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.866 · Cited by 664
Chemotherapy Use, Performance Status, and Quality of Life at the End of Life
Prigerson, H. G., Bao, Y., Shah, M. A., Paulk, M. E., LeBlanc, T. W., Schneider, B. J., Garrido, M. M., Reid, M. C., Berlin, D. A., Adelson, K. B., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2378 · Cited by 645
Greer, J. A., Pirl, W. F., Jackson, V. A., Muzikansky, A., Lennes, I. T., Heist, R. S., Gallagher, E. R., & Temel, J. S. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.7996 · Cited by 574
Mack, J. W., Cronin, A., Keating, N. L., Taback, N., Huskamp, H. A., Malin, J. L., Earle, C. C., & Weeks, J. C. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.6055 · Cited by 560
Self-citationBalboni, T. A., Paulk, M. E., Balboni, M. J., Phelps, A. C., Loggers, E. T., Wright, A. A., Block, S. D., Lewis, E. F., Peteet, J. R., & Prigerson, H. G. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.8005 · Cited by 536
Self-citationPhelps, A. C. (2009) · JAMA · doi:10.1001/jama.2009.341 · Cited by 462
Hui, D., Kim, S. H., Roquemore, J., Dev, R., Chisholm, G., & Bruera, E. (2014) · Cancer · doi:10.1002/cncr.28628 · Cited by 454
Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer
Sultana, A., Smith, C. T., Cunningham, D., Starling, N., Neoptolemos, J. P., & Ghaneh, P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2551 · Cited by 442
Long‐Term Trends in Medicare Payments in the Last Year of Life
Riley, G. F., & Lubitz, J. D. (2010) · Health Services Research · doi:10.1111/j.1475-6773.2010.01082.x · Cited by 442
Family Perspectives on Aggressive Cancer Care Near the End of Life
Wright, A. A., Keating, N. L., Ayanian, J. Z., Chrischilles, E. A., Kahn, K. L., Ritchie, C. S., Weeks, J. C., Earle, C. C., & Landrum, M. B. (2016) · JAMA · doi:10.1001/jama.2015.18604 · Cited by 424
Self-citationEnd-of-Life Care Discussions Among Patients With Advanced Cancer: A Cohort Study
Mack, J. W., Cronin, A., Taback, N., Huskamp, H. A., Keating, N. L., Malin, J. L., Earle, C. C., & Weeks, J. C. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-3-201202070-00008 · Cited by 420
“Previous work has suggested indirectly that discussions occur late in the course of illness, leading, for example, to hospice referrals that occur within days of death (21, 22).”
BackgroundInfluentialSelf-citationHo, T. H., Barbera, L., Saskin, R., Lu, H., Neville, B. A., & Earle, C. C. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.9897 · Cited by 416
Self-citationMatsuyama, R., Reddy, S., & Smith, T. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.6236 · Cited by 403
Evaluating claims-based indicators of the intensity of end-of-life cancer care
Earle, C. C., Neville, B. A., Landrum, M. B., Souza, J. M., Weeks, J. C., Block, S. D., Grunfeld, E., & Ayanian, J. Z. (2005) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzi061 · Cited by 391
Self-citationBalboni, T. A., Balboni, M., Enzinger, A. C., Gallivan, K., Paulk, M. E., Wright, A., Steinhauser, K., VanderWeele, T. J., & Prigerson, H. G. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.903 · Cited by 359
Greer, J. A., Jackson, V. A., Meier, D. E., & Temel, J. S. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21192 · Cited by 345
Physician factors associated with discussions about end‐of‐life care
Keating, N. L., Landrum, M. B., Rogers, S. O., Baum, S. K., Virnig, B. A., Huskamp, H. A., Earle, C. C., & Kahn, K. L. (2010) · Cancer · doi:10.1002/cncr.24761 · Cited by 345
Self-citationThe intensity and variation of surgical care at the end of life: a retrospective cohort study
Kwok, A. C., Semel, M. E., Lipsitz, S. R., Bader, A. M., Barnato, A. E., Gawande, A. A., & Jha, A. K. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61268-3 · Cited by 342
Wright, A. A., Zhang, B., Keating, N. L., Weeks, J. C., & Prigerson, H. G. (2014) · BMJ · doi:10.1136/bmj.g1219 · Cited by 340
Self-citationBalboni, T., Balboni, M., Paulk, M. E., Phelps, A., Wright, A., Peteet, J., Block, S., Lathan, C., VanderWeele, T., & Prigerson, H. (2011) · Cancer · doi:10.1002/cncr.26221 · Cited by 330
Self-citationQuality of end‐of‐life care in patients with hematologic malignancies: A retrospective cohort study
Hui, D., Didwaniya, N., Vidal, M., Shin, S. H., Chisholm, G., Roquemore, J., & Bruera, E. (2014) · Cancer · doi:10.1002/cncr.28614 · Cited by 315
The Role of Chemotherapy at the End of Life: “When Is Enough, Enough?”
Harrington, S. E., & Smith, T. J. (2008) · JAMA · doi:10.1001/jama.299.22.2667 · Cited by 280
Smith, A. K., Fisher, J., Schonberg, M. A., Pallin, D. J., Block, S. D., Forrow, L., Phillips, R. S., & McCarthy, E. P. (2009) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2008.08.022 · Cited by 268
Self-citationResurrecting Treatment Histories of Dead Patients: A Study Design That Should Be Laid to Rest
Bach, P. B., Schrag, D., & Begg, C. B. (2004) · JAMA · doi:10.1001/jama.292.22.2765 · Cited by 255
Nipp, R. D., El‐Jawahri, A., Moran, S. M., D'Arpino, S. M., Johnson, P. C., Lage, D. E., Wong, R. L., Pirl, W. F., Traeger, L., Lennes, I. T., et al. (2017) · Cancer · doi:10.1002/cncr.30912 · Cited by 230
Looking Beyond Where Children Die: Determinants and Effects of Planning a Child's Location of Death
Dussel, V., Kreicbergs, U., Hilden, J. M., Watterson, J., Moore, C., Turner, B. G., Weeks, J. C., & Wolfe, J. (2009) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2007.12.017 · Cited by 210
Self-citationDepression and end-of-life care for patients with cancer
Rosenstein, D. L. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/drosenstein · Cited by 92
Trends in receiving chemotherapy for advanced cancer patients at the end of life
Lee, H. S., Chun, K. H., Moon, D., yeon, H. K., Lee, S., & Lee, S. (2015) · BMC Palliative Care · doi:10.1186/s12904-015-0001-7 · Cited by 67
In Chemotherapy for Lung Cancer, Sometimes Less is More
Roeland, E., Loprinzi, C., Moynihan, T. J., Smith, T. J., & Temel, J. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0034 · Cited by 13
Dieudonné-Rahm, N., Burkhardt, S., & Pautex, S. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1325-6 · Cited by 4
Metadata
- Authors
- Earle, C. C., Neville, B. A., Landrum, M. B., Ayanian, J. Z., Block, S. D., & Weeks, J. C.
- Venue
- Journal of Clinical Oncology
- Published
- 2004-01-15
- Volume
- 22
- Issue
- 2
- Pages
- 315-321
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2096448257
- Cited by
- 987
- References
- 24
- FWCI
- 25.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.